Showing results (91-100 of 121) with videos related to
Sort By:
Pageof 13
Asian Journal of Pharmaceutical Sciences|June 5, 2023
KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomesXinbo Qiao, Yixiao Zhang, Zhan Zhang, et al.Proceedings of the National Academy of Sciences of the United States of America|December 5, 2018
FSIP1 regulates autophagy in breast cancerCaigang Liu, Lisha Sun, Jie Yang, et al.Elife|July 28, 2021
Association of human breast cancer CD44-/CD24- cells with delayed distant metastasisXinbo Qiao, Yixiao Zhang, Lisha Sun, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 4, 2022
A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+CD24- enriched breast cancer stem-like cellsCaigang Liu, Yixiao Zhang, Jiujiao Gao, et al.Cell Death & Disease|October 14, 2016
XAB2 functions in mitotic cell cycle progression via transcriptional regulation of CENPEShuai Hou, Na Li, Qian Zhang, et al.Oncotarget|November 8, 2017
Predicting level 2 axillary lymph node metastasis in a Chinese breast cancer population post-neoadjuvant chemotherapy: development and assessment of a new predictive nomogramCaigang Liu, Yanlin Jiang, Xin Gu, et al.Nature Communications|May 5, 2023
KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancerJiawen Bu, Yixiao Zhang, Sijin Wu, et al.Elife|February 6, 2023
Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: Retrospective cohort studyNan Niu, Yinan Zhang, Yang Bai, et al.Elife|March 14, 2022
Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancerYixiao Zhang, Lisha Sun, Haonan Li, et al.Science China. Life Sciences|July 17, 2023
FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathwayGuanglei Chen, Lisha Sun, Xi Gu, et al.Pageof 13